Studies in individuals with type 2 diabetes revealed a 1.11.7 kg reduction in body weight and a 0.790.89% (8.79.78 mmol/mol) decrease in HbA 1c [34]
doi: 10.3390/biomedicines13010018
Tirzepatide is a medication that combines the effects of two hormonesglucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)
Now recognised as an epidemic, there is increasing pressure on hospitals and clinics, as the centre of care, to treat obesity and other related diseases medically. ADDRESSING THE BURDEN OF OBESITY AND OTHER METABOLIC DISEASES The pervasiveness of obesity continues to be staggering
Learn more A meat-free, plant-packed meal plan that delivers hunger-busting protein from beans, soy, eggs and dairy
Clinical evidence shows: 14 to 22% total body weight loss in clinical trials Preferential reduction of visceral (belly) fat over subcutaneous fat Improved insulin sensitivity within 4 to 8 weeks Reduced liver fat (NAFLD improvement) in 60 to 70% of patients Sustained appetite regulation